Atopic dermatitis (AD) patients achieving minimal disease activity (MDA) based on both clinician and patient-reported outcomes had fewer flares, shorter flares, reduced healthcare resource utilization, and a higher rate of patient-reported disease control when compared with patients who met one or neither optimal target. Vimal Hasmukh Prajapati, MD, FRCPC, a Clinical Associate Professor at the University of Calgary and Co-founder/Co-director of … Continue reading Shared-decision Making in AD: Incorporating the Minimal Disease Activity Concept With Vimal Hasmukh Prajapati, MD, FRCPC